Advertisement
U.S. Markets closed

Sea Mild Biotechnology Co., Ltd. (7516.TWO)

Taipei Exchange - Taipei Exchange Delayed Price. Currency in TWD
9.20-0.34 (-3.56%)
At close: 02:59PM CST
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
257,018
257,018
202,649
163,816
207,880
Cost of Revenue
200,647
200,647
166,494
144,728
180,598
Gross Profit
56,371
56,371
36,155
19,088
27,282
Operating Expense
51,538
51,538
48,183
52,620
66,126
Operating Income
4,833
4,833
-12,028
-33,532
-38,844
Net Non Operating Interest Income Expense
-669
-669
-597
-726
-1,083
Pretax Income
6,132
6,132
-21,483
-41,995
-47,253
Tax Provision
-55
-55
-103
10,056
8,250
Net Income Common Stockholders
6,187
6,187
-21,380
-52,051
-55,503
Diluted NI Available to Com Stockholders
6,187
6,187
-21,380
-52,051
-55,503
Basic EPS
-0.01
-
-1.11
-2.70
-2.87
Diluted EPS
-0.01
-
-1.11
-2.70
-2.87
Basic Average Shares
19,309
-
19,309
19,309
19,309
Diluted Average Shares
19,309
-
19,309
19,309
19,309
Total Expenses
252,185
252,185
214,677
197,348
246,724
Net Income from Continuing & Discontinued Operation
6,187
6,187
-21,380
-52,051
-55,503
Normalized Income
6,187
6,187
-21,427
-53,285
-57,320
Interest Income
296
296
84
106
41
Interest Expense
965
965
681
832
1,124
Net Interest Income
-669
-669
-597
-726
-1,083
EBIT
7,097
7,097
-20,802
-41,163
-46,129
EBITDA
21,582
21,582
-5,634
-20,326
-25,246
Reconciled Cost of Revenue
200,647
200,647
166,494
144,728
180,598
Reconciled Depreciation
14,485
14,485
15,168
20,837
20,883
Net Income from Continuing Operation Net Minority Interest
6,187
6,187
-21,380
-52,051
-55,503
Total Unusual Items Excluding Goodwill
0
0
47
1,542
2,271
Total Unusual Items
0
0
47
1,542
2,271
Normalized EBITDA
21,582
21,582
-5,681
-21,868
-27,517
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0.2253
308.4
454.2